But agency says it cannot definitively rule out a like to blood clots
This is not the definitive kind of ‘this is safe’ ruling we’d all like.
Search Web: EU drug agency concludes that AstraZeneca benefits outweigh the risks
Recent Posts
- S&P 500 Holds Losses Despite Pullback in Short-Term Consumer Inflation Expectations
- Gold Price Forecast: Gold Threatens Larger Break, 1854 Support in Sight
- Markets Week Ahead: Dow Jones, US Dollar, Gold, Euro, Fed, CPI, China
- S&P 500 Outlook: Equities Drop Ahead of Peloton, Disney and Alibaba Earnings
- USD/JPY Forecast – Setting Up for the Next Leg Higher?
ZH-CN
EN
FR
DE
ES